Hallucinations in Parkinson's Disease

Last updated: October 13, 2020
Sponsor: Olaf Blanke
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04592965
UH_PD
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Investigation on how robotically mediated sensorimotor stimulation induces and triggers presence hallucinations in different clinical groups of parkinsonian patients, and in aged-matched controls

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with Parkinson's disease (expect for healthy controls)

  • Able to understand instructions and provide informed consent.

  • Native speaking language of experimental site (or acquisition of language ofexperimental site before 6 years old).

  • Montreal Cognitive Assessment (Nasreddine & Patel, 2016) with score ≥ 22.

  • Able to manipulate the robotic device.

Exclusion

Exclusion Criteria:

  • For PD patients only: Neurological comorbidities other than Parkinson's disease (e.g.Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic braininjury, epilepsy, chronic migraine, etc.)

  • For healthy controls only: Parkinson's disease or other neurological illnesses

  • History or current condition of substance abuse and/or dependence (e.g., alcohol,drugs).

  • Suffering from or diagnosed with psychiatric illnesses according to DSM-V criteria (e.g., schizophrenia, bipolar disorders, autism, personality disorders, phobia etc.).

  • Family history (1st and 2nd degree) of psychiatric disorders (e.g., schizophrenia orbipolar disorders).

  • Severe somatic illnesses (e.g., cancer).

  • Severe tremors or physical disability preventing optimal use of robotic device.

  • Participating in a pharmacological study.

  • Local or general anaesthesia 30 days prior experiment

  • Inability to provide informed consent (legal guardianship)

  • For the MRI part only: body weight exceeding 160kg, implanted metallic devices,implant for deep brain stimulation, foreign metallic objects, unstable angina,cardio-vascular diseases, tattoos with metallic components, external metallic objects,claustrophobia, pregnancy.

Study Design

Total Participants: 40
Study Start date:
August 17, 2020
Estimated Completion Date:
December 01, 2021

Study Description

Parkinson's Disease (PD) is a condition mostly known and characterized by motor symptoms, such as tremors, rigidity, bradykinesia, amongst others. Yet, recent bodies of research have identified a significant number of non-motor symptoms that also accompany the unfolding of this disease. These non-motor symptoms mainly focus on hallucinations that will develop with the course of the disease, and will affect approximately 50% of the patients suffering from Parkinson's. This number rises to 70% if minor hallucinations, mild phenomena and poorly-structured hallucinations, are included. Despite the potential impact in the patients' lives, and previous efforts to study these phenomena, the brain changes that underly hallucinations in PD are still poorly understood. With the current study the investigators aim to improve this understanding, by studying the most common minor hallucination in Parkinson's Disease, the Presence Hallucination (PH), which can be defined as the strange sensation of perceiving someone behind when no one is actually there. To study it in a controlled manner, the investigators will induce this hallucination with an extensively verified paradigm, which gives rise to this sensation through robotically-mediated sensorimotor stimulation, in both healthy individuals, and PD patients. The researchers intend to discern the sensitivity of different groups of PD patients to the induction of this hallucination, by targeting PD patients, with hallucinations including PH, with hallucinations but without PH, without any hallucinations, and an aged match control group with no neurological comorbidities. The investigators intended to extend previous work on the induction of the PH in PD patients, by identifying the neural correlates of this induction in these patients, in a similar fashion to previous work in healthy individuals. Moreover, the researchers also intend to extend the general understanding of the basis for hallucinations in PD by extending what was done in previous work, to more stratified cohorts of PD patients, that will not only be analysed in terms of static during rest, but also in terms of dynamic connectivity, and will also perform the PH-inducing task in the scanner, as mentioned before.

Connect with a study center

  • Hospital de la Santa Creu I Sant Pau

    Barcelona, 08041
    Spain

    Site Not Available

  • Centre Hospitalier Universitaire Vaudois

    Lausanne, Vaud 1011
    Switzerland

    Site Not Available

  • Inselspital

    Bern, 1310
    Switzerland

    Active - Recruiting

  • Campus Biotech

    Geneva, 1202
    Switzerland

    Site Not Available

  • Geneva University Hospital

    Geneva, 1202
    Switzerland

    Active - Recruiting

  • Hôpital du Valais

    Sion, 1951
    Switzerland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.